40
NewcelX Ltd. raises $2.9M under Reg D
Company raise · Closed · Offering $2.9M · Sold $2.9M · Kloten, Switzerland · filed 2026-08-24
40
NewcelX Ltd. raises $3.4M under Reg D
Company raise · Closed · Kloten, Switzerland · Form D filed 2026-05-13
Why now — by persona
Relevant to: Executive & technical recruiting, B2B software & services sales, Commercial banking / treasury, D&O and management-liability insurance, Outsourced accounting / CFO. Lead card pending.
People on the filing
| Olivier C. Samuel | Director |
| Tamar C. Galili | Director |
| Kfir Molakandov | Executive Officer, Director |
| Michel Revel | Executive Officer, Director |
| Eran C. Iohan | Director |
| Omri Hagai | Chief Financial Officer |
| Liora C. Oren | Director |
| Alexander C. Zwyer | Executive Officer, Director |
| Ronen Twito | Executive Chairman and Chief Executive Officer |
Signed by Ronen Twito, Chief Executive Officer.
Filing contact
The issuer's phone number and address from the filing are shown to subscribers. See plans, or read it on EDGAR.
Other filings by this issuer
35
NLS Pharmaceutics Ltd. raises $1M under Reg D
Company raise · Closed · Offering $1M · Sold $1M · Zurich, Switzerland · filed 2025-07-10
40
NLS Pharmaceutics Ltd. raises $2M under Reg D
Company raise · Closed · Offering $2M · Sold $2M · Zurich, Switzerland · filed 2025-04-14
25
NLS Pharmaceutics Ltd. raises $500K under Reg D
Company raise · Closed · Offering $500K · Sold $500K · Zurich, Switzerland · filed 2025-01-22
45
NLS Pharmaceutics Ltd. raises $7.2M under Reg D
Company raise · Closed · Offering $7.2M · Sold $7.2M · Zurich, Switzerland · filed 2024-10-21